Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 616 of 6351
-
New drug tarlatamab takes on tough lung cancers
Disease control Recruiting nowUNLOCK TARLATAMAB is an open-label, single arm, multicenter, phase 2 platform study that aims to evaluate the mechanisms of action and resistance to tarlatamab in metastatic/locally advanced Small-Cell Lung Cancer (SCLC) with any level of DLL3 expression and in other poorly diffe…
Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Sep 10, 2026 04:00 UTC
-
New rapid test could save lives of febrile children in africa
Diagnosis Recruiting nowThe overall aim of the study is to provide evidence that introducing novel biomarkers evaluation at triaging (first clinical assessment), in combination with IMCI-based guidelines (SoC), is a viable strategy to enhance rapid and accurate identification of febrile children at incr…
Sponsor: Barcelona Institute for Global Health • Aim: Diagnosis
Last updated Jul 30, 2026 00:00 UTC
-
New drug duo offers hope for hard-to-treat head and neck cancer
Disease control Recruiting nowThe purpose of this study to find out whether sacituzumab govitecan in combination with cetuximab is an effective and safe treatment approach for people with recurrent and/or metastatic head and neck squamous cell cancer (HNSCC).
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Engineered immune cells take on lupus and scleroderma in early trial
Disease control By invitation onlyThis study will have two Phases: Phase 1a and Phase 1b. The goal of this clinical study is to learn more about the study drug KITE-363, to establish dosing, tolerability, safety, and preliminary efficacy of KITE-363 in participants with refractory autoimmune diseases. The primar…
Phase 1 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
VA launches program to bring precision cancer care to more veterans
Disease control Recruiting nowThe investigators are rolling out a 3 level intervention designed to improve the use of Precision Oncology at 8 VA medical centers. The 3 components of the intervention are 1: a short educational video for patients, 2: audit and feedback to providers on their Precision Oncology p…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New hope for hard-to-treat myeloma: experimental combo tested in phase 2 trial
Disease control Recruiting nowThis is a single - arm, multi - cohort, open - label, multi - center Phase II clinical study. It aims to evaluate the efficacy and safety of F182112 combined with different administration regimens in patients with relapsed or refractory multiple myeloma.
Phase 2 • Sponsor: Shandong New Time Pharmaceutical Co., LTD • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Stem cells injected into spine: hope for paralysis?
Disease control Recruiting nowThis Phase I clinical trial is designed to evaluate the safety, tolerability of XS228 ( iPSC-Derived Motor Neuron Progenitor Cells) in patients with Subacute Spinal Cord Injury
Phase 1 • Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Gut bacteria and minerals: a new hope for ulcerative colitis remission?
Disease control Recruiting nowthe goal of this interventional observational study is to To evaluate the efficacy , safety of lactobacillus probiotics or trace elements when added to (ulcerative colitis) infliximab in maintaining remission in UC patients and to To compare the efficacy of adding lactobacillus p…
Phase 4 • Sponsor: National Hepatology & Tropical Medicine Research Institute • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can simple reminders keep children safe from malaria after hospital?
Disease control Recruiting nowThe proposed research aims to conduct implementation trials in Benin, co-designed with national stakeholders, to evaluate different delivery strategies for optimizing health system delivery of post-discharge malaria chemoprevention (PDMC) drugs and adherence to PDMC. This chemopr…
Phase 4 • Sponsor: Institut de Recherche Clinique du Benin • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New COPD drug shows promise in cutting lung Flare-Ups
Disease control OngoingThe purpose of this study is to assess the efficacy and safety of verekitug (UPB-101) in participants with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD), an inflammatory lung disease.
Phase 2 • Sponsor: Upstream Bio Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a common ED drug boost fertility in PCOS?
Disease control CompletedThe goal of this randomized clinical trial is to compare the effectiveness of clomiphene citrate alone with clomiphene citrate combined with sildenafil citrate for inducing ovulation and achieving pregnancy in women with polycystic ovary syndrome (PCOS) who have difficulty becomi…
Phase 4 • Sponsor: Nishtar Medical University • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New hepatitis b drug shows promise in large trial
Disease control OngoingUsingTAF as the control, the nvestigators aim to further explore the efficacy and safety of different dosages of HTS in the treatment of patients with chronic hepatitis B; ultimately, the nvestigators determine the optimal recommended dosage of HTS to provide a basis for Phase II…
Phase 2/3 • Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Brain-Wash breakthrough? new trial takes on deadly ventriculitis
Disease control Recruiting nowVentriculitis is a severe infectious disease of the central nervous system with diverse etiologies. Currently, the treatment for ventriculitis is challenging, with poor prognosis. The mortality rate of ventriculitis is generally reported to be higher than 30%, with the highest re…
Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Cord blood cells take on stomach cancer: new hope in Late-Stage trial
Disease control Recruiting nowThis project employs a prospective, double-blind, randomized controlled trial methodology to comparatively analyze the safety and survival outcomes of human umbilical cord blood RAK cells applied in advanced gastric cancer. Firstly, the maximum tolerated dose (MTD) of RAK cell th…
Phase 2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Spinal implant trial aims to help paralyzed patients walk again
Disease control Recruiting nowThe primary objective of this clinical trial is to investigate the efficacy of Epidural Electrical Stimulation (EES) in restoring motor and sensory function in patients with chronic spinal cord injury (SCI) at levels T11-L3, classified as ASIA B-D. The study aims to address the f…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Less cutting, same cure? new trial tests smaller surgery for rectal cancer
Disease control OngoingThe goal of this clinical trial is to learn evaluate the safety and efficacy of reduced surgical resection margins in patients with local advanced upper rectal or rectosigmoid junction tumors who met the ycT≤3N0M0 regression following neoadjuvant therapy. The main questions it ai…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
5,000 smokers to test new digital nudge vs. standard care in cancer prevention trial
Prevention OngoingThe purpose of this study is to evaluate the comparative effectiveness of two different informatics-enabled implementation strategies on increasing tobacco treatment and improving smoking cessation rates for cancer control and prevention. This will be done via a two-arm pragmatic…
Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jul 12, 2026 00:00 UTC
-
Immune cells engineered to fight lymphoma enter human testing
Disease control Recruiting nowThis is an open label clinical study: Phase Ia is a dose escalation phase, evaluating the safety, tolerability, RP2D, PK characteristics, and preliminary efficacy of IBR900 cell injection in the treatment of relapsed/refractory B-cell non Hodgkin lymphoma (NHL); Phase Ib is the d…
Phase 1 • Sponsor: Imbioray (Hangzhou) Biomedicine Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Beetroot juice and High-Intensity exercise may protect Post-Menopausal hearts
Disease control Recruiting nowMenopause greatly increases cardiovascular disease risk (CVD). Current exercise guidelines are inadequate to ameliorate this risk and higher intensity exercise may be necessary for cardiovascular benefits in postmenopausal females. Oral nitrate supplementation enhances exercise p…
Sponsor: University of Virginia • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Rewiring the veteran brain: could visual training counteract cognitive decline?
Knowledge-focused OngoingOlder veterans with a history of mild brain trauma exhibit early cognitive challenges, especially in driving-related tasks. This is attributed to alterations in the brain's excitatory/inhibitory (E/I) balance. This pilot project investigates this phenomenon by leveraging electroe…
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC